Wells Fargo & Company Generation Bio Co. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GBIO
# of Institutions
83Shares Held
49.9MCall Options Held
100Put Options Held
200-
Price T Rowe Associates Inc Baltimore, MD9.51MShares$22.6 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$19.7 Million3.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.92MShares$9.33 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$7.84 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$7.1 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $140M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...